Discontinued — last reported Q4 '25
Zimmer Biomet Holdings EMEA — Segment Assets increased by 1.4% to $737.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.5%, from $655.00M to $737.00M.
Growth in assets relative to revenue may indicate declining asset turnover, while stable assets with growing revenue suggest improved operational efficiency.
This metric represents the total value of resources controlled by the EMEA segment, including inventory, accounts receiv...
Standard segment reporting metric; peers in global medical technology report this to demonstrate regional scale and capital allocation.
zbh_segment_emea_segment_assets| Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $664.00M | $679.00M | $655.00M | $705.00M | $748.00M | $727.00M | $737.00M |
| QoQ Change | — | +2.3% | -3.5% | +7.6% | +6.1% | -2.8% | +1.4% |
| YoY Change | — | +2.3% | -3.5% | — | — | — | +12.5% |